# A Non-inferiority, Comparative Study Between Foraseq®, Eurofarma´s Formoterol/Budesonide and Alenia® in Asthma

> **NCT01167010** · PHASE3 · COMPLETED · sponsor: **Eurofarma Laboratorios S.A.** · enrollment: 552 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Formoterol/Budesonide
- **DRUG:** Foraseq
- **DRUG:** Alenia

## Key facts

- **NCT ID:** NCT01167010
- **Lead sponsor:** Eurofarma Laboratorios S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2011-08
- **Final completion:** 2012-02
- **Target enrollment:** 552 (ACTUAL)
- **Last updated:** 2025-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01167010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01167010, "A Non-inferiority, Comparative Study Between Foraseq®, Eurofarma´s Formoterol/Budesonide and Alenia® in Asthma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01167010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*